{"id":169208,"date":"2021-12-23T00:00:00","date_gmt":"2021-12-23T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/m360va0030-medtech-vascular-access-devices-market-insights-asia\/"},"modified":"2026-04-21T11:04:48","modified_gmt":"2026-04-21T11:04:48","slug":"m360va0030-medtech-vascular-access-devices-market-insights-asia-pacific","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360va0030-medtech-vascular-access-devices-market-insights-asia-pacific\/","title":{"rendered":"Vascular Access Devices &#8211; Market Insights &#8211; Asia Pacific"},"content":{"rendered":"<p>Over the forecast period, the Asia Pacific vascular access device market will <span>grow moderately<\/span> through 2030, driven by an expanding patient population and increasing adoption of premium-priced devices. Importantly, vascular access devices represent a key component of care for <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> patients, and therefore the pandemic\u2019s impact on procedure volumes, unit sales, and revenues has been incorporated into market projections.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for vascular access devices in the Asia Pacific countries across an 11-year period.<\/p>\n<p class=\"question-statement\"><strong>The <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> global pandemic has had a dual effect on the vascular access market in the short term.<\/strong><\/p>\n<p>How have trends in vascular access device segments changed due to <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr>?<\/p>\n<p>What factors contribute to these market changes?<\/p>\n<p>What plans are being executed by manufacturers in response to the pandemic?<\/p>\n<p>How soon will procedure volumes, sales, and revenues recover to pre-pandemic levels?<\/p>\n<p class=\"question-statement\"><strong>Despite increasing failure rates and complications requiring reinsertion, short <abbr title=\"Peripheral Intravenous Catheter\">PIVC<\/abbr> insertions continue to be one of the most common invasive procedures in the region.<\/strong><\/p>\n<p>What are the current clinical recommendations to reduce <abbr title=\"Peripheral Intravenous Catheter\">PIVC<\/abbr> failure?<\/p>\n<p>What are some of the measures taken by companies to improve <abbr title=\"Peripheral Intravenous Catheter\">PIVC<\/abbr> insertion outcomes?<\/p>\n<p>How will initiatives to educate nurses on <abbr title=\"Peripheral Intravenous Catheter\">PIVC<\/abbr> insertion impact the unit sales of short <abbr title=\"Peripheral Intravenous Catheter\">PIVC<\/abbr>?<\/p>\n<p class=\"question-statement\"><strong>Many competitors\u2019\u00a0products are entering the vascular access device market in Asia Pacific.<\/strong><\/p>\n<p>How will new products launches impact the vascular access device market?<\/p>\n<p>What challenges will new companies encounter in this space? Will they capture significant share from existing competitors?<\/p>\n<p class=\"question-statement\"><strong>Increasing incidence of <abbr title=\"Central-Line\u2013Associated Bloodstream Infection\">CLABSI<\/abbr> with <abbr title=\"Central Venous Catheter\">CVC<\/abbr> is resulting in a shift toward <abbr title=\"Peripherally Inserted Central Catheter\">PICC<\/abbr>s. <\/strong><\/p>\n<p>How is the rising adoption of <abbr title=\"Peripherally Inserted Central Catheter\">PICC<\/abbr>s impacting the sales of <abbr title=\"Central Venous Catheter\">CVC<\/abbr> units? How does this vary across the Asia Pacific countries?<\/p>\n<p>What are the marketing strategies adopted by companies to promote <abbr title=\"Peripherally Inserted Central Catheter\">PICC<\/abbr> sales?<\/p>\n<p>What are some of the clinical practices initiated to reduce <abbr title=\"Central-Line\u2013Associated Bloodstream Infection\">CLABSI<\/abbr> with <abbr title=\"Central Venous Catheter\">CVC<\/abbr>s? How will this impact the <abbr title=\"Central Venous Catheter\">CVC<\/abbr> market?<\/p>\n<p>How will the markets for tunneled <abbr title=\"Central Venous Catheter\">CVC<\/abbr>s and antimicrobial devices perform through 2030?<\/p>\n<p class=\"question-statement\"><strong>Home care therapy continues to grow in most Asia Pacific countries.<\/strong><\/p>\n<p>What are some of the vascular access device markets likely to be impacted by the increasing adoption of home care therapy?<\/p>\n","protected":false},"template":"","class_list":["post-169208","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-vascular-access-devices","medtech-geography-asia-pacific","medtech-date-949"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/169208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/169208\/revisions"}],"predecessor-version":[{"id":282425,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/169208\/revisions\/282425"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=169208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}